DIRS.INFO The most relevant business & tech news

☆ The charts of these under-the-radar health-care stocks look great, says top technical analyst
▼ + stars: | 2023-04-10 | by ( Brian Evans | ) www.cnbc.com time to read: +1 min

Some under-the-radar health-care stocks are unlikely attractive picks, according to Renaissance Macro Research chairman Jeff deGraaf. "From a cyclical standpoint even within the health-care sector, they're starting to break out." DeGraaf listed Stryker , Bruker and Boston Scientific as "good looking, long-term charts" thanks to both their discretionary spend and chart cyclicality within the health-care space. BRKR YTD mountain Healthcare equipment stocks are some of the most attractive picks in the overall sector, according to Renaissance Macro Research chief Jeff DeGraaf. Health-care stocks are often touted as defensive investments during economic turmoil and recessions thanks to their predictable earnings and steady consumer growth.

RBC Capital Markets anticipates that the next quarter could be choppy for stocks, but the firm shared its list of high-conviction names to navigate the volatility. With these concerns in mind, RBC shared a list of high-conviction stocks that it says are well-positioned to offer upside this quarter. Below are 10 of the names: Alnylam Pharmaceuticals and biotech engineering stock Boston Scientific are new additions to RBC's list of high-conviction names. RBC analyst Shagun Singh said Boston Scientific is "positioned to drive consistent double-digit EPS growth," with upcoming device launches and trial data readouts to act as catalysts. On the energy front, RBC named oil company Diamondback Energy as one of its top picks for the quarter.

☆ These 12 stocks are holding up despite the banking crisis and are expected to keep doing well
▼ + stars: | 2023-03-16 | by ( Sarah Min | ) www.cnbc.com time to read: +3 min

While the banking crisis has sent the broader market for a loop, some stocks are holding up well — and are expected to see more gains. The Swiss bank stock rose 3% on Thursday. Despite the recent sharp swings in the market, there are some stocks are holding up. CNBC Pro screened the S & P 500 for stocks that up 1% or more this month and at least 1% this year. The telecommunications stock is rated buy by roughly 74% of analysts, and has risen 1.6% this month, and 3.2% in 2023.

☆ Here are JPMorgan's top stock picks heading into February
▼ + stars: | 2023-02-01 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

JPMorgan added fresh names to its top stock picks for February, including a medical tech company that's rallied sharply to begin the year. For February, JPMorgan added five new names to its Focus List: Cenovus Energy , CMS Energy , Rogers Communications , Stryker and Treace Medical Concepts . The medical tech stock is up 12% year to date. JPMorgan said new additions CMS Energy and Cenovus Energy are uniquely positioned within the industry, according to the note. Amazon's stock fell more than 30% during the past 12 months, but it has rallied to start the year, up more than 24% in 2023.

☆ Morning Bid: A quart and two halves
▼ + stars: | 2023-02-01 | by ( ) www.reuters.com time to read: +5 min

A look at the day ahead in U.S. and global markets from Mike Dolan. February kicked off on Wednesday without too much trepidation about how all that will pan out. Before the Fed announcement, ADP releases its January private sector employment readout for last month and markets will also scan the December JOLTS job openings report. While markets await the 'Triple-A' of Big Tech releases on Thursday, Meta (META.O) is due to report later today and the dour news from elsewhere in the tech sector kept coming. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

☆ Here comes the biggest week of earnings. Plus an AI ode to the Dow
▼ + stars: | 2023-01-28 | by ( Zev Fima | ) www.cnbc.com time to read: +7 min

While only six companies in the Dow Jones Industrial Average are reporting next week, about 20% of the S & P 500 reports, making it the biggest week of earnings this season. The Dow and the S & P 500 gained 2.2% and 2.9% this week, respectively, while the Nasdaq Composite rose 4.7%. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

☆ Stocks may face an inflection point in the week ahead as the Fed meets and Apple posts earnings
▼ + stars: | 2023-01-27 | by ( Patti Domm | In | ) www.cnbc.com time to read: +9 min

The Fed's meeting Tuesday and Wednesday comes amid a flood of corporate earnings reports, with about 20% of the S & P 500 reporting that week. The most important day for earnings is Thursday, when Apple , Alphabet and Amazon report after the bell. The Nasdaq Composite was up 11% for the month as of Friday afternoon, well ahead of the 6.2% gain in the S & P 500. Traders have been watching the S & P 500 edge closer to the key threshold of 4,100 , its high from December. AAPL 1Y line apple Apple is also important because of the signals it can send about the strength of the consumer, supply chains and China's reopening.

☆ Markets rally on signs inflation is abating, as investors look to next week's consumer price data
▼ + stars: | 2023-01-06 | by ( Zev Fima | ) www.cnbc.com time to read: +5 min

Later in the day, markets were also buoyed by the ISM's nonmanufacturing purchasing managers' index, which said the services industry contracted last month. The next big test will be December's consumer price index report, to be released Thursday. Meanwhile, the fourth-quarter earnings season kicks off next Friday, when the banks – including Club holding Wells Fargo (WFC) – are set to report. On Thursday, the December ADP employment report was released, showing an additional 235,000 jobs, well above the 153,000 expected by analysts. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

Nov 22 (Reuters) - Medtronic Plc (MDT.N) on Tuesday lowered its full-year outlook for profit and revenue growth, blaming a stronger dollar and a slower-than-anticipated recovery in supply chain disruptions, sending the medical device maker's shares down nearly 6%. Medtronic cut its revenue growth expectations for fiscal 2023 to 3.5% to 4%, from 4% to 5%. The company said cost-cutting measures will likely offset lower revenue and inflationary pressures in the second half of the year. A slower-than-anticipated recovery in supply chain disruptions impacted Medtronic's medical surgical business the most, with the unit's revenue falling 10% to $2.07 billion. Reporting by Khushi Mandowara and Bhanvi Satija in Bengaluru; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.

☆ Morning Bid: Consumer drain as banks gain
▼ + stars: | 2022-10-26 | by ( ) www.reuters.com time to read: +5 min

Google's results in particular bode ill for Facebook parent Meta Platforms (META.O), especially reliant on advertising and reporting its results late on Wednesday. Consumer blues contrasted with bumper earnings from banks who are raking in huge windfalls from rising interest rates - direct cash injections from reserves they hold at central banks along with higher net interest margins and trading revenues flattered by volatile markets. read more read more read more read moreEuropean banks reporting this week matched Wall St counterparts on that score, raising conundrums for the European Central Bank meeting this week and Bank of England and U.S. Federal Reserve gatherings next week. They all plan further policy rate rises to rein in inflation - but this also involves direct transfers to their banks and potentially a drain on government finances. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.

☆ Earnings are off to a surprisingly decent start. Next week is the big test for tech
▼ + stars: | 2022-10-21 | by ( Jim Cramer | ) www.cnbc.com time to read: +7 min

Stocks rallied this week as earnings season ramped up and is so far off to a better-than-expected start. With 20% of the S & P 500 having reported financials so far, sales results have thus far been 1.4% above expectations while earnings results are 5.4% above expectations, in aggregate. That inverse correlation between bond yields and stocks was powerful enough to trump positive earnings reports. Looking back On the earnings front, we got results from Johnson & Johnson (JNJ), Procter & Gamble (PG), and Danaher (DHR). As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.

☆ What Cramer is watching Tuesday — J&J beat, Salesforce gets an activist, stocks surge
▼ + stars: | 2022-10-18 | by ( Jim Cramer | ) www.cnbc.com time to read: +5 min

What I am looking at Tuesday, Oct. 18, 2022 Club holding Johnson & Johnson (JNJ) reports an impressive quarter. Activist investor Starboard takes a major stake in Club holding Salesforce (CRM), sees significant opportunity. Club holding Microsoft (MSFT) cuts people, continues to invest, but calls for slowest quarterly revenue growth in more than five years. Barclays cuts price target on Charles Schwab (SCHW) to $73 per share from $81. Barclays cuts price target on Unity Software (U) to $33 per share from $49.

☆ Cramer's lightning round: I like Boston Scientific over Medtronic
▼ + stars: | 2022-09-22 | by ( Krystal Hur | ) www.cnbc.com time to read: 1 min

Loading chart...Boston Scientific Corp: "I've worked and seen doctors with their stuff. Loading chart...Occidental Petroleum Corp: "I'm going to say you can stick with Occidental." Loading chart...SoFi Technologies Inc: "This stock is too cheap. The CEO is going to make you money if you buy that stock at $5.36." Loading chart...Energy Transfer LP: "[Investor] Lee Cooperman said the other day that he thinks Energy Transfer is good.

☆ Only 18 out of 890 major US companies are fully transparent on worker issues — and that openness is helping them grow their bottom line
▼ + stars: | 2019-04-17 | by ( Richard Feloni | ) www.businessinsider.com time to read: +6 min

Only 18 companies disclosed all nine of the practices taken into consideration, including Goldman Sachs, Nike, Nvidia, and PepsiCo. Just's team of researchers gathered all public data on nine criteria related to what it calls "human capital." The team discovered that only 18 of the companies both disclosed and tracked the progress of all the criteria. It was initially acceptable to simply state a policy, but then stakeholders demanded increasingly extensive data and signs of progress. "I don't think that you have much of a choice these days, if you're a larger company," she said.

Persons: Paul Tudor Jones, Russell, Goldman Sachs, It's, Martin Whittaker, you've, it's, Whittaker, Alison, millennials, Eli Lilly, Jones Lang LaSalle, Read, Tonie Hansen, Hansen Organizations: Nike, Nvidia, PepsiCo, Service, ROE, Data Systems, Boston Scientific, Hasbro, Intel, PayPal, Qualcomm, State, Symantec, Texas Instruments Locations: BusinessInsider.com, Wall, Silicon, America, Marriott, Wells

Search resuls for: "Boston Scientific"

14 mentions found